Pyrazine-based tubulin inhibitors
US8084456B2 · kind B2 · utility
13Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2003 |
| Grant date | Dec 27, 2011 |
| Priority date | — |
| Expiry date | Aug 26, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/650952
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.